<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36437985</PMID><DateRevised><Year>2022</Year><Month>11</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1663-4365</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in aging neuroscience</Title><ISOAbbreviation>Front Aging Neurosci</ISOAbbreviation></Journal><ArticleTitle>Cognitive impairments in patients with subacute coronavirus disease: Initial experiences in a post-coronavirus disease clinic.</ArticleTitle><Pagination><StartPage>994331</StartPage><MedlinePgn>994331</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">994331</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fnagi.2022.994331</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">A significant number of patients experience persistent cognitive impairment after coronavirus disease (COVID-19). This study aimed to investigate the cognitive function of patients in the subacute phase of COVID-19 and to identify the clinical factors associated with cognitive sequelae.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="UNASSIGNED">Data from patients who visited the psychiatric department of our post-COVID clinic between March and May 2022 were analyzed. The results of neuropsychiatric function tests, including the digit span forward (attention/processing speed) and backward (working memory) tests, the trail making test part A (attention/processing speed) and part B (executive functioning), and the Stroop word color interference test (executive functioning), as well as clinical data from 40 patients in the subacute phase of COVID-19 were analyzed. We calculated the frequency of impairments in each cognitive measure, defined as a z-score of &#x2264;-1.5 standard deviations below measure-specific age- and sex-adjusted norms.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Of the participants, 72.5% (<i>n</i> = 29) had impairments in at least one cognitive domain. Impairment in executive function was the most frequent (64.9%), followed by impairments in processing speed/attention (52.5%) and working memory (42.5%). Age was inversely correlated with T scores in all cognitive function tests.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Regular examination of cognitive function is needed, especially in elderly individuals, regardless of the subjective symptom manifestations.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Chang, Ha, Lee and Lee.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Jhin Goo</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Myongji Hospital, Hanyang University College of Medicine, Goyang-si, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ha</LastName><ForeName>Eun-Hye</ForeName><Initials>EH</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Myongji Hospital, Hanyang University College of Medicine, Goyang-si, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Wangjun</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Office of the Chief Executive Officer and Chairman, Myongji Hospital, Goyang-si, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Su Young</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Myongji Hospital, Hanyang University College of Medicine, Goyang-si, South Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Aging Neurosci</MedlineTA><NlmUniqueID>101525824</NlmUniqueID><ISSNLinking>1663-4365</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cognitive function</Keyword><Keyword MajorTopicYN="N">cognitive sequelae</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">neurocognitive function test</Keyword><Keyword MajorTopicYN="N">subacute phase</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>28</Day><Hour>4</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>29</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36437985</ArticleId><ArticleId IdType="pmc">PMC9681802</ArticleId><ArticleId IdType="doi">10.3389/fnagi.2022.994331</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aoun Sebaiti M., Hainselin M., Gounden Y., Sirbu C. A., Sekulic S., Lorusso L., et al. (2022). Systematic review and meta-analysis of cognitive impairment in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Sci. Rep. 12:2157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8828740</ArticleId><ArticleId IdType="pubmed">35140252</ArticleId></ArticleIdList></Reference><Reference><Citation>Badenoch J. B., Rengasamy E. R., Watson C., Jansen K., Chakraborty S., Sundaram R. D., et al. (2022). Persistent neuropsychiatric symptoms after COVID-19: A systematic review and meta-analysis. Brain Commun. 4:fcab297.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8833580</ArticleId><ArticleId IdType="pubmed">35169700</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaud V., Crottaz-Herbette S., Dunet V., Vaucher J., Bernard-Valnet R., Du Pasquier R., et al. (2021). Pattern of cognitive deficits in severe COVID-19. J. Neurol. Neurosurg. Psychiatry 92 567&#x2013;568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8053331</ArticleId><ArticleId IdType="pubmed">33219042</ArticleId></ArticleIdList></Reference><Reference><Citation>Biagianti B., Di Liberto A., Edoardo A. N., Lisi I., Nobilia L., de Ferrabonc G. D., et al. (2022). Cognitive assessment in SARS-CoV-2 patients: A systematic review. Front. Aging Neurosci. 14:909661. 10.3389/fnagi.2022.909661</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.909661</ArticleId><ArticleId IdType="pmc">PMC9283975</ArticleId><ArticleId IdType="pubmed">35847679</ArticleId></ArticleIdList></Reference><Reference><Citation>Buysse D. J., Reynolds C. F., III, Monk T. H., Berman S. R., Kupfer D. J. (1989). The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research. Psychiatry Res. 28 193&#x2013;213. 10.1016/0165-1781(89)90047-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-1781(89)90047-4</ArticleId><ArticleId IdType="pubmed">2748771</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli E. T., Barrett K. M. S., Riffle S., Bolze A., Neveux I., Dabe S., et al. (2020). Long-term COVID-19 symptoms in a large unselected population. Medrxiv [Preprint] 10.1101/2020.10.07.20208702</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.07.20208702</ArticleId></ArticleIdList></Reference><Reference><Citation>Crivelli L., Palmer K., Calandri I., Guekht A., Beghi E., Carroll W., et al. (2022). Changes in cognitive functioning after COVID-19: A systematic review and meta-analysis. Alzheimers Dement. 18 1047&#x2013;1066. 10.1002/alz.12644</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12644</ArticleId><ArticleId IdType="pmc">PMC9073922</ArticleId><ArticleId IdType="pubmed">35297561</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H. E., Assaf G. S., McCorkell L., Wei H., Low R. J., Re&#x2019;em Y., et al. (2021). Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 38:101019. 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>de Melo G. D., Lazarini F., Levallois S., Hautefort C., Michel V., Larrous F., et al. (2021). COVID-19&#x2013;related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci. Transl. Med. 13:eabf8396. 10.1126/scitranslmed.abf8396</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abf8396</ArticleId><ArticleId IdType="pmc">PMC8158965</ArticleId><ArticleId IdType="pubmed">33941622</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., McCarthy P., et al. (2022). SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature 604 697&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Ermis U., Rust M. I., Bungenberg J., Costa A., Dreher M., Balfanz P., et al. (2021). Neurological symptoms in COVID-19: A cross-sectional monocentric study of hospitalized patients. Neurol. Res. Pract. 3 1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7953515</ArticleId><ArticleId IdType="pubmed">33712089</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham E. L., Clark J. R., Orban Z. S., Lim P. H., Szymanski A. L., Taylor C., et al. (2021). Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 &#x201c;long haulers&#x201d;. Ann. Clin. Transl. Neurol. 8 1073&#x2013;1085. 10.1002/acn3.51350</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Groiss S. J., Balloff C., Elben S., Brandenburger T., M&#xfc;ttel T., Kindgen-Milles D., et al. (2020). Prolonged neuropsychological deficits, central nervous system involvement, and brain stem affection after COVID-19&#x2014;a case series. Front. Neurol. 11:574004. 10.3389/fneur.2020.574004</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.574004</ArticleId><ArticleId IdType="pmc">PMC7674620</ArticleId><ArticleId IdType="pubmed">33224088</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo P., Benito Ballesteros A., Yeung S. P., Liu R., Saha A., Curtis L., et al. (2022a). COVCOG 1: Factors predicting physical, neurological and cognitive symptoms in long COVID in a community sample. A first publication from the COVID and cognition study. Front. Aging Neurosci. 14:804922. 10.3389/fnagi.2022.804922</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.804922</ArticleId><ArticleId IdType="pmc">PMC8968323</ArticleId><ArticleId IdType="pubmed">35370617</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo P., Benito Ballesteros A., Yeung S. P., Liu R., Saha A., Curtis L., et al. (2022b). COVCOG 2: Cognitive and memory deficits in long COVID: A second publication from the COVID and cognition study. Front. Aging Neurosci. 14:804937. 10.3389/fnagi.2022.804937</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.804937</ArticleId><ArticleId IdType="pmc">PMC8967943</ArticleId><ArticleId IdType="pubmed">35370620</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A., Chatfield D. A., Jolly A., Trender W., Hellyer P. J., Del Giovane M., et al. (2022). Multivariate profile and acute-phase correlates of cognitive deficits in a COVID-19 hospitalised cohort. EClinicalMedicine 47:101417. 10.1016/j.eclinm.2022.101417</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101417</ArticleId><ArticleId IdType="pmc">PMC9048584</ArticleId><ArticleId IdType="pubmed">35505938</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A., Trender W., Chamberlain S. R., Jolly A., Grant J. E., Patrick F., et al. (2020). Cognitive deficits in people who have recovered from COVID-19 relative to controls: An N= 84,285 online study. MedRxiv [Preprint] 10.1101/2020.10.20.20215863</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.20.20215863</ArticleId><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellmuth J., Barnett T. A., Asken B. M., Kelly J. D., Torres L., Stephens M. L., et al. (2021). Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients. J. Neurovirol. 27 191&#x2013;195. 10.1007/s13365-021-00954-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-021-00954-4</ArticleId><ArticleId IdType="pmc">PMC7852463</ArticleId><ArticleId IdType="pubmed">33528824</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J., Kremer S., Merdji H., Clere-Jehl R., Schenck M., Kummerlen C., et al. (2020). Neurologic features in severe SARS-CoV-2 infection. N. Engl. J. Med. 382 2268&#x2013;2270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7179967</ArticleId><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka M. T., Golenbock D., Latz E., Morgan D., Brown R. (2020). Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res. Ther. 12 1&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7271826</ArticleId><ArticleId IdType="pubmed">32498691</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosp J. A., Dressing A., Blazhenets G., Bormann T., Rau A., Schwabenland M., et al. (2021). Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain 144 1263&#x2013;1276. 10.1093/brain/awab009</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab009</ArticleId><ArticleId IdType="pmc">PMC8083602</ArticleId><ArticleId IdType="pubmed">33822001</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung Y. H., Ha E.-H., Choe K. W., Lee S., Jo D. H., Lee W. J. (2022). Persistent symptoms after acute COVID-19 infection in omicron era. J. Korean Med. Sci. 37:e213. 10.3346/jkms.2022.37.e213</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2022.37.e213</ArticleId><ArticleId IdType="pmc">PMC9274102</ArticleId><ArticleId IdType="pubmed">35818704</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandemirli S. G., Dogan L., Sarikaya Z. T., Kara S., Akinci C., Kaya D., et al. (2020). Brain MRI findings in patients in the intensive care unit with COVID-19 infection. Radiology 297 E232&#x2013;E235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7507997</ArticleId><ArticleId IdType="pubmed">32384020</ArticleId></ArticleIdList></Reference><Reference><Citation>Kouzuki M., Furukawa S., Mitani K., Urakami K. (2021). Examination of the cognitive function of Japanese community-dwelling older adults in a class for preventing cognitive decline during the COVID-19 pandemic. PLoS One 16:e0248446. 10.1371/journal.pone.0248446</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0248446</ArticleId><ArticleId IdType="pmc">PMC8668118</ArticleId><ArticleId IdType="pubmed">34898633</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J. H., Jeong H. S., Lim S. M., Cho H. B., Ma J.-Y., Ko E., et al. (2013). Reliability and validity of the fatigue severity scale among university student in South Korea. Korean J. Biol. Psychiatry 20 6&#x2013;11.</Citation></Reference><Reference><Citation>Mazza M. G., Palladini M., De Lorenzo R., Magnaghi C., Poletti S., Furlan R., et al. (2021). Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up. Brain Behav. Immun. 94 138&#x2013;147. 10.1016/j.bbi.2021.02.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.02.021</ArticleId><ArticleId IdType="pmc">PMC7903920</ArticleId><ArticleId IdType="pubmed">33639239</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe9;ndez R., Balanz&#xe1;-Mart&#xed;nez V., Luperdi S. C., Estrada I., Latorre A., Gonz&#xe1;lez-Jim&#xe9;nez P., et al. (2021). Short-term neuropsychiatric outcomes and quality of life in COVID-19 survivors. J. Intern. Med. 290 621&#x2013;631. 10.1111/joim.13262</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13262</ArticleId><ArticleId IdType="pmc">PMC8013333</ArticleId><ArticleId IdType="pubmed">33533521</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak K., Johnsen S., Sattler S., Nielsen S., Kunalan K., Rungby J., et al. (2021). Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables. Eur. Neuropsychopharmacol. 46 39&#x2013;48. 10.1016/j.euroneuro.2021.03.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2021.03.019</ArticleId><ArticleId IdType="pmc">PMC8006192</ArticleId><ArticleId IdType="pubmed">33823427</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M. V., McGroder C., Stevens J. S., et al. (2021). Post-acute COVID-19 syndrome. Nat. Med. 27 601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T., Hittle M., Goodman S. N. (2021). Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: A systematic review. JAMA Netw. Open 4:e2111417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Laughlin K. N., Thompson M., Hota B., Gottlieb M., Plumb I. D., Chang A. M., et al. (2022). Study protocol for the innovative support for patients with SARS-COV-2 infections registry (INSPIRE): A longitudinal study of the medium and long-term sequelae of SARS-CoV-2 infection. PLoS One 17:e0264260. 10.1371/journal.pone.0264260</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0264260</ArticleId><ArticleId IdType="pmc">PMC8893622</ArticleId><ArticleId IdType="pubmed">35239680</ArticleId></ArticleIdList></Reference><Reference><Citation>Praschan N., Josephy-Hernandez S., Kim D. D., Kritzer M. D., Mukerji S., Newhouse A., et al. (2021). Implications of COVID-19 sequelae for health-care personnel. Lancet Respir. Med. 9 230&#x2013;231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834418</ArticleId><ArticleId IdType="pubmed">33444540</ArticleId></ArticleIdList></Reference><Reference><Citation>Snaith R. P. (2003). The hospital anxiety and depression scale. Health Qual. Life Outcomes 1 1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC183845</ArticleId><ArticleId IdType="pubmed">12914662</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Dercon Q., Luciano S., Geddes J. R., Husain M., Harrison P. J. (2021). Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 18:e1003773. 10.1371/journal.pmed.1003773</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolentino J. C., Gjorup A. L. T., Schmidt G. J., Schmidt S. L. (2021). Early attention impairment in a patient with COVID-19. Psychiatry Clin. Neurosci. 75 66&#x2013;67. 10.1111/pcn.13178</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pcn.13178</ArticleId><ArticleId IdType="pmc">PMC7753571</ArticleId><ArticleId IdType="pubmed">33241874</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss D. S. (2007). &#x201c;The impact of event scale: Revised,&#x201d; in Cross-cultural assessment of psychological trauma and PTSD, eds Wilson J. P., Tang C. S. k. (Boston, MA: Springer; ), 219&#x2013;238. 10.3390/jpm12050681</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12050681</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO (2022). Coronavirus (COVID-19) dashboard | WHO Coronavirus (COVID-19) dashboard with vaccination data]. Geneva: WHO.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>